Therapeutics Focus
Our physicians have specialized our algorithms to be normalized and optimized for specific therapeutic types within the following disease categories
Pancreatic Cancer
Microtubule inhibitors, mTOR inhibitors, Thymidilate synthase inhibitors, Topoisomerase I inhibitors, Tyrosine Kinase inhibitors, VEGF inhibitors, ALK inhibitors, Monoclonal antibodies, PD-1 antibody
Breast Cancer
Monoclonal antibodies, Aromatase inhibitor, Anti-HER2 antibodies, HER2 receptor inhibitors, CDK4 inhibitors, PI3K inhibitors, Tyrosine kinase inhibitors, GnRH agonist, PARP inhibitors, TRK Inhibitors
Prostate Cancer
CYP171A1 inhibitors, Nonsteroidal antiandrogen, GnRH antagonist, LHRH agonist, PARP inhibitors, Poly ADP ribose polymerase inhibitors, PD-1 antibody, 17a-hydroxylase inhibitors Antifungal
Non-Small Cell Lung Cancer
Anti-EGFR, Anti-VEGF, Tyrosine Kinase inhibitors, ALK inhibitors, RAF inhibitors, MEK inhibitors, mTOR inhbibitors, EGFR inhibitors, c-MET inhibitors
Small Cell Lung Cancer
Monoclonal antibodies, mTOR inhbibitors, Mammalian target of rapamycin inhibitors, Immune checkpoint inhibitors, PD-1 antibody, PD-L1 antibody
Melanoma
Kinase inhibitors, Monoclonal antibodies, BRAF inhibitors, MEK inhibitors, CTLA-4 antibody, PD-1 antibody, PD-L1 antibody, MEK inhibitors
Multiple Myeloma
Antibody drug conjugate, Anti-BCMA antibody, Anti-CD269 antibody, Proteasome inhibitors, Anti-CD38 antibody, Angiogenesis inhibitors, Exportin-1 inhibitors, Angiogenesis inhibitors, BCL-2 inhibitors,
Gastric Cancer
Anti-VEGFR, HER2 receptor inhibitors, Anti-HER2 antibodies, Topoisomerase I inhibitors, PD-1 antibody, Antibody drug conjugate, Monoclonal antibodies, HER2/neu receptor antagonist
Bladder Cancer
Monoclonal antibodies, PD-L1 antibody, Tyrosine kinase inhibitors, FGFR inhibitors, Organonitrogen compounds, Anti-Nectin-4 antibody, Microtubule inhibitor, PD-1 antibody, DNA synthesis inhibitors
Renal Cell Cancer
mTOR inhbibitors, Interleukin-2, Anti-VEGFR, Angiogenesis inhibitors, Tyrosine kinase inhibitors, c-MET inhibitors, AXL inhibitor, CTLA-4 antibody, PD-1 antibody
Colorectal Cancer
Anti-VEGFR, CTLA-4 antibody, PD-1 antibody, VEGFR2 inhibitors, Recombinant Fusion Protein, Anti-HER2 antibody, Topoisomerase I inhibitor, ALK inhibitors, BRAF kinase inhibitor
Rheumatoid Arthritis
RCOX-1 inhibitors, COX-2 selective inhibitors, Corticosteroids, Intra-articular corticosteroids, Tumor necrosis factor inhibitors, Interleukin-1 receptor antagonists, Interleukin-6 (IL-6) Inhibitors, T-cell costimulatory blocking agents, B cell depleting agents
Crohn’s Disease
Corticosteroids, Immunomodulators, Monoclonal antibodies, Anti-integrin biologics
Ulcerative Collitis
5-aminosalicylates, Corticosteroids, Monoclonal antibodies, Immunomodulators, Tumor necrosis factor inhibitors
Lupus
Immunomodulators, Anti-malarials, COX-1 inhibitors, COX-2 inhibitors
Psoriasis
Corticosteroids, Calcineurin inhibitors, Immunomodulators, Monoclonal antibodies, Vitamin D analogues
Celiac Disease
Zonulin receptor antagonist
Cystic Fibrosis
CFTR modulators
Other rare hematological & genetic conditions
Biologics Enzyme replacement therapy Gene therapy
